The FDA under the Trump administration declines to review Moderna's new mRNA flu vaccine application, citing trial design issues. Moderna requests a meeting. The decision may discourage vaccine development and create future supply uncertainties.
FDA Rejects Modernas mRNA Flu Shot
✨ Enjoying this article? ✨
📱 Get more with the NewsNuggs iOS App →